Pharmacological Inhibition of Inositol Hexakisphosphate Kinase 1 Protects Mice against Obesity-Induced Bone Loss

Obesity and type II diabetes mellitus (T2DM) are prominent risk factors for secondary osteoporosis due to the negative impacts of hyperglycemia and excessive body fat on bone metabolism. While the armamentarium of anti-diabetic drugs is expanding, their negative or unknown impacts on bone metabolism...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Siddaraju V. Boregowda, Manjunatha K. Nanjappa, Cori N. Booker, Jacqueline Strivelli, Valentina M. Supper, Paul S. Cooke, Donald G. Phinney
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2022-08-01
Saila:	Biology
Gaiak:	diet high fat obesity osteoporosis anti-obesity drugs inositol hexakisphosphate kinase 1
Sarrera elektronikoa:	https://www.mdpi.com/2079-7737/11/9/1257
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!